Position in ICCC
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$587,441
+$232,772 QoQ
Shares Held
58,452
+4.3% QoQ
Ownership
0.644%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 30 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 79%
Shared 18%
None 3%
Common Shares in ICCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,868 across 230 Biotechnology names. ICCC ranks #175 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ICCC
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $587,441 | 58,452 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $354,669 | 56,030 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $333,827 | 54,281 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $389,405 | 62,305 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $486,872 | 69,953 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $324,411 | 67,727 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $341,475 | 66,306 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $263,835 | 72,682 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $320,434 | 66,069 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $336,024 | 63,401 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $292,424 | 57,451 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $307,551 | 57,594 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $321,320 | 64,264 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $333,794 | 64,689 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $379,236 | 62,170 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $168,890 | 22,579 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $182,629 | 21,016 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $187,142 | 19,393 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $155,144 | 19,393 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $192,011 | 20,514 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $184,376 | 19,408 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $145,525 | 15,096 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||